Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Avian paramyxovirus 1

ABSTRACT: Newcastle Disease Virus samples from outbreaks in 1951-2015 in West Java, Indonesia

PROVIDER: PRJNA613298 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11593162_1.fastq.gz	Fastqsanger.gz
	SRR11593162_2.fastq.gz	Fastqsanger.gz
	SRR11593163_1.fastq.gz	Fastqsanger.gz
	SRR11593163_2.fastq.gz	Fastqsanger.gz
	SRR11593164_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

avian paramyxovirus 1

Project description:Genome of a new strain of Newcastle Disease Virus

| PRJNA522017 | ENA

avian paramyxovirus 1 strain:Komarov

Project description:Host and Newcastle disease virus transcriptomics of NDV infected DF1 cells

| PRJNA1123209 | ENA

Avian avulavirus 1

Project description:The newly emerged Newcastle disease virus strains in Indonesia Raw sequence reads

| PRJNA613953 | ENA

avian paramyxovirus 8

Project description:avian paramyxovirus 8 Genome sequencing

| PRJNA213664 | ENA

avian paramyxovirus 1

Project description:Avian Avulavirus Genome sequencing

| PRJNA889548 | ENA

avian paramyxovirus 1

Project description:avian paramyxovirus 1 Raw sequence reads

| PRJNA1064681 | ENA

Project description:E. coli isolates from a livestock farm in Sukabumi city, West Java, Indonesia

| PRJNA1075840 | ENA

E-GEOD-18791

Project description:Transcription profiling by array of human dendritic cells infected with Newcastle Disease Virus

2025-01-24 | E-GEOD-18791 | ExpressionAtlas

Interferon-γ inhibition of Ebola virus infection [Monocyte-derived macrophage]

Project description:Episodic Ebola virus (EBOV) outbreaks, such as the current one in West Africa, emphasize the critical need for novel antivirals against this highly pathogenic virus. Here, we demonstrate that interferon gamma (IFNγ) prevents morbidity and mortality associated with EBOV infection when administered to mice either 24 hours prior to or 2 hours following EBOV infection. Microarray studies with IFNγ-stimulated human macrophages identified novel interferon-stimulated genes (ISGs) that inhibit EBOV infection upon ectopic expression. IFNγ treatment reduced viral RNA levels in macrophages to a similar degree as cells treated with the protein synthesis inhibitor, cycloheximide, suggesting that IFNγ treatment inhibits genome replication. As IFNγ treatment robustly protects mice against EBOV infection, we propose that this FDA-approved drug may serve as a useful prophylactic or therapeutic strategy during EBOV outbreaks, contributing to the currently limited arsenal of filovirus antivirals.

2015-10-20 | GSE64996 | GEO

Interferon-γ inhibition of Ebola virus infection [Alveolar macrophage]

2015-10-20 | GSE64995 | GEO